Medtronic (MDT -1.1% AH) is subpoenaed over false data in a 2008 study of its bone-growth...

|About: Medtronic plc (MDT)|By:, SA News Editor

Medtronic (MDT -1.1% AH) is subpoenaed over false data in a 2008 study of its bone-growth product. The company disclosed that U.S. attorneys requested information about a former Army surgeon who wrote the study; Army officials raised concerns about the data to a publishing journal, who retracted the article.